Skip to main content
. Author manuscript; available in PMC: 2014 Sep 18.
Published in final edited form as: Eur J Nucl Med Mol Imaging. 2007 May 5;34(11):1823–1831. doi: 10.1007/s00259-007-0427-0

Fig. 5.

Fig. 5

Metabolic stability of 18F-FPRGD2 in mouse blood and urine samples and in liver, kidney, and U87MG tumor homogenates at 1 h after injection. The HPLC profile of pure 18F-FPRGD2 (Standard) is also shown